Results 191 to 200 of about 98,492 (221)
Some of the next articles are maybe not open access.

Tuberculosis and HIV Coinfection

Seminars in Respiratory and Critical Care Medicine, 2013
The human immunodeficiency virus (HIV) pandemic has amplified the global burden of tuberculosis (TB), particularly in sub-Saharan Africa, where 82% of the world's TB/HIV coinfection exists. HIV infection significantly increases the risk of developing and dying from TB and was associated with 350,000 TB deaths in 2010. The diagnosis of HIV-associated TB
Jacob M, Gray, David L, Cohn
openaire   +2 more sources

Cholera‐schistosomiasis coinfection dynamics

Optimal Control Applications and Methods, 2019
SummaryThe present work investigates the coinfection dynamics of the cholera and schistosomiasis diseases. The steady states of the model are examined. We obtain results for the model in detail and present the stability results whenever the basic reproduction number is less than unity ( ).
K.O. Okosun   +3 more
openaire   +2 more sources

The Other Coinfection

2021
Abstract Patients may have an acute hepatitis B virus (HBV) and hepatitis D virus (HDV) coinfection from concurrent transmission, or they may have HDV superinfection of a chronic HBV infection. HBV and HDV coinfection can present as a mild, self-limited infection, but it may progress to fulminant hepatitis or cirrhosis for 20% of ...
Eugene M. Tan   +2 more
openaire   +1 more source

HIV/HBV Coinfection

Current Hepatology Reports, 2015
Hepatitis B and human immunodeficiency virus (HIV) infections share transmission patterns and risk factors, which explains high prevalence of chronic hepatitis B virus (HBV) infection in HIV-infected patients. Furthermore, thanks to combination of antiretroviral therapies, natural history of HIV infection has changed, and liver diseases became one of ...
Marion Corouge   +2 more
openaire   +1 more source

Coinfection: Doing the Math

Science Translational Medicine, 2013
A transmission model clarifies the effects of influenza on pneumococcal pneumonia and bridges the gap between individual animal experiments and human epidemiological data.
openaire   +2 more sources

Pathogenesis of HIV-HCV coinfection

Current Infectious Disease Reports, 2007
Hepatitis C virus (HCV) and HIV-1 are often harbored in the same host, establishing chronic infections typically characterized by persistent viremia. HIV-1 has deleterious effects on the course of HCV infection by increasing the rate of HCV viral persistence, quantitative HCV RNA levels, and ultimately the liver fibrosis progression rate.
Arthur Y, Kim, Georg M, Lauer
openaire   +2 more sources

Leprosy coinfection with kala‐azar

International Journal of Dermatology, 2009
AbstractLeprosy and visceral leishmanias are endemic in Nepal and are both major public health problems. Two patients of visceral leishmaniasis developed leprosy during the course of the disease. Leprosy and visceral leishmaniasis share a similar immunological spectrum and can occur concomitantly in endemic regions.
Arpana, Rijal   +2 more
openaire   +2 more sources

HIV and hepatitis C coinfection

Journal of Gastroenterology and Hepatology, 2008
AbstractThe significant burden of HIV/hepatitis C virus (HCV) coinfection is increasingly recognized worldwide, and in particular within the Asia–Pacific region. Individuals who are coinfected with both viruses are at risk from accelerated liver disease and consequently cirrhosis, liver failure, and hepatocellular carcinoma.
Gail V, Matthews, Gregory J, Dore
openaire   +2 more sources

[HIV-tuberculosis coinfection].

Annales de medecine interne, 2003
Coinfection with the human immunodeficiency virus (HIV) and tuberculosis is a major public health problem throughout the world. In subsaharan Africa and Southeast Asia, as many as one third of all patients with tuberculosis also have HIV infection. These two infection interact on each other, worsening the prognosis and increasing mortality.
Sibylle, Bévilacqua   +2 more
openaire   +1 more source

[Cytomegalovirus coinfection].

Klinicka mikrobiologie a infekcni lekarstvi
The rapid advancement of modern pharmacological and surgical therapeutic interventions is often accompanied by potential disruptions to the immune system, both permanent and transient. Consequently, life-threatening infectious complications may emerge, which were either absent or exceedingly rare in the past.
Svatava, Snopková   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy